Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2008-06-10
2008-06-10
Devi, S. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S203100, C424S234100, C424S184100, C424S249100, C514S002600, C530S350000, C530S825000
Reexamination Certificate
active
07384645
ABSTRACT:
A composition is prepared from a mixture of different vesicles, such as outer membrane vesicles (OMVs) and vaccines are based thereon. Another composition comprises in a single vesicle a combination of antigens and/or other vesicle components deriving from separate vesicles; again vaccines are prepared therefrom.
REFERENCES:
patent: 6180111 (2001-01-01), Stein et al.
patent: 6451317 (2002-09-01), Blake et al.
patent: 6936261 (2005-08-01), Granoff et al.
patent: 7081244 (2006-07-01), Robinson et al.
patent: 2003/0021812 (2003-01-01), Robinson et al.
patent: 2003/0026809 (2003-02-01), Robinson et al.
patent: 2003/0215469 (2003-11-01), Robinson et al.
patent: WO 90/06696 (1990-06-01), None
patent: WO 97/05899 (1997-02-01), None
patent: WO 00/25811 (2000-05-01), None
patent: WO 00/50074 (2000-08-01), None
patent: WO 01/09350 (2001-02-01), None
patent: WO 01/52885 (2001-07-01), None
patent: WO 01/91788 (2001-12-01), None
Ferreiros et al. FEMS Microbiol. Lett. 83: 247-254, 1991.
Griffis et al. Trans. Roy. Soc. Trop. Med. Hyg. 85: 32-36, 1991.
United Kingdom Search Report for Great Britain Application No. 0130123.3, UK Paten Office, UK, mailed Aug. 19, 2002.
Bracegirdle, P., et al., “Neisseria lactamicaProvides a Cross-reactive Vaccine Against Meningococcal Disease,”Program and Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy40:248, American Society for Microbiology (Sep. 2000).
Cartwright, K., et al., “Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins,”Vaccine17:2612-2619, Elsevier Science Ltd. (1999).
International Search Report for International Patent Application No. PCT/GB02/05718, European Patent Office, Netherlands, mailed May 7, 2003.
Foster Keith Alan
Gorringe Andrew Richard
Hudson Michael John
Reddin Karen Margaret
Robinson Andrew
Devi S.
Health Protection Agency
Sterne Kessler Goldstein & Fox P.L.L.C.
LandOfFree
Outer membrane vesicles from gram negative bacteria and use... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Outer membrane vesicles from gram negative bacteria and use..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Outer membrane vesicles from gram negative bacteria and use... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2804513